Trials Sponsors Conditions Drugs Pricing

Conditions

Heart Implant Complication

Keywords

left ventricular assist device (LVAD)heartimplantartificial

Outcome Measures

Primary Outcomes (2)

30 days mortality
mortality rate 30 days after receiving the LVAD implant
30 days after surgery
rehospitalization rate
rehospitalization rate of patients after receiving the LVAD implant
between day of surgery and 31.12.2019

Secondary Outcomes (1)

survival rate
between day of surgery and 31.12.2019

Study Arms (1)

Patients with an implanted LVAD

Patients which received an implantation of a left ventricular assist device (LVAD) at the University Hospital Basel since 2014

Other: collection of patient data

Interventions

collection of patient dataOther

assess mortality rate, rehospitalization and survival rate of patients after receiving an artificial heart implant

Patients with an implanted LVAD

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Sexall

Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

Sampling MethodProbability Sample

Study Population

Patients who received an LVAD implant

You may qualify if:

Patients who received an LVAD implant

You may not qualify if:

Sponsors & Collaborators

University Hospital, Basel, Switzerland
Otherlead

Study Sites (1)

Herzchirurgie University Hospital Basel

Basel, 4031, Switzerland

Related Publications (1)

Schaeffer T, Pfister O, Mork C, Mohacsi P, Rueter F, Scheifele S, Morgen A, Zenklusen U, Doebele T, Maurer M, Erb J, Fassl J, Cueni N, Siegemund M, Pargger H, Gahl B, Osswald S, Eckstein F, Grapow M. 5-year results of a newly implemented mechanical circulatory support program for terminal heart failure patients in a Swiss non-cardiac transplant university hospital. J Cardiothorac Surg. 2021 Mar 31;16(1):64. doi: 10.1186/s13019-021-01447-5.
PMID: 33789723DERIVED

Study Officials

Martin Grapow, Prof Dr. med.
HerzZentrum Hirslanden Zürich
PRINCIPAL INVESTIGATOR

Enrollment

20 participants (actual enrollment reported by the registry).

Study Design

Study Type: observational
Observational Model: COHORT
Time Perspective: PROSPECTIVE
Sponsor Type: OTHER
Responsible Party: SPONSOR

Study Record Dates

First Submitted

February 6, 2020

First Posted

February 10, 2020

Study Start

December 1, 2019

Actual (reported)

Establishment of a LVAD Destination Program in a Swiss Non Cardiac Transplant University Hospital

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

Study Start

Primary Completion

Study Completion

First Submitted

First Posted

Conditions

Keywords

Outcome Measures

Primary Outcomes (2)

Secondary Outcomes (1)

Study Arms (1)

Patients with an implanted LVAD

Interventions

Eligibility Criteria

You may qualify if:

You may not qualify if:

Sponsors & Collaborators

Study Sites (1)

Related Publications (1)

Study Officials

Enrollment

Study Design

Study Record Dates

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

Primary Completion

Study Completion

First Submitted

First Posted

Conditions

Keywords

Outcome Measures

Primary Outcomes (2)

Secondary Outcomes (1)

Study Arms (1)

Patients with an implanted LVAD

Interventions

Eligibility Criteria

You may qualify if:

You may not qualify if:

Sponsors & Collaborators

Study Sites (1)

Related Publications (1)

Study Officials

Enrollment

Study Design

Study Record Dates

Source record

Locations